Company Filing History:
Years Active: 1990-1997
Title: Frank A Gentile: Innovator in Pharmaceutical Chemistry
Introduction
Frank A Gentile is a notable inventor based in Wayne, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on innovative compounds that have potential therapeutic applications.
Latest Patents
Gentile's latest patents include groundbreaking research on indolocarbazoles derived from the microorganism Saccharothrix aerocolonigenes copiosa subsp. nov. This patent details N-alkanoyl derivatives of staurosporine, which are represented by a specific formula. These compounds are designed to inhibit myosin light chain kinase and protein kinase C, as well as to combat tumor cell proliferation. Additionally, he has developed pharmaceutical compositions that exhibit antihypertensive and anti-inflammatory effects in warm-blooded animals, including humans. Another significant patent involves an antimicrobial compound isolated from Actinomadura fulva subsp. indica, which is a macrolactam disaccharide produced through controlled fermentation.
Career Highlights
Frank A Gentile is currently associated with Schering Corporation, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic agents that address various health challenges.
Collaborations
Throughout his career, Gentile has collaborated with esteemed colleagues, including Ann C Horan and Mahesh G Patel. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Frank A Gentile's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in therapeutic solutions.